Our expertise

Polestar Insights is a healthcare consultancy providing clients with quality decision-support based on our unique blend of market research, marketing and commercialisation expertise.

We have gained this from front-line strategic and operational roles across the pharmaceutical industry and healthcare consultancy organisations, 

including global new product commercialisation, working at the interface between research, development and marketing.

Polestar Insights has been established by two experienced pharmaceutical industry professionals who have worked on both the client and service sides of the industry.


We provide both a deep understanding of customers' needs and the capabilities to design and deliver research that provides robust, meaningful insights, that drive actionable recommendations, robust assumptions, and defendable product valuations. We also have the industry experience to be able to effectively support implementation. 

 

POLESTAR
insights

We Are

 

Alan Kent

Eric Sharp

Over 25 years of experience including top 20 pharma company Marketing Director positions at both local and global levels, including head of new product strategic marketing. Alan was previously a Senior Principal for IQVIA, focusing on market research and product commercialisation. 

Over 25 years of experience with Marketing Director positions in four countries. Eric has also worked for three market research companies. Eric was recently the Launch Excellence Manager for Baxalta.

  • LinkedIn - Grey Circle
  • LinkedIn - Grey Circle
 

We Provide

POLESTAR
insights

Expertise and experience in market research, marketing, and new product commercialisation

We Deliver

 

Combined experience of  over 50 years encompassing biopharmaceutical industry local and global marketing and new product commercialisation, market research and consultancy.

We have access to 170,000 HCPs globally and patients in over 25 therapy areas in 30 countries.

Mobile data collection techniques, leading to an immediacy of results from both HCPs and patients. 

Combined experience of  over 50 years encompassing biopharmaceutical industry local and global marketing and new product commercialisation, market research and consultancy.

Effective research design, analysis, and interpretation, with actionable  recommendations, robust assumptions and defendable new product valuations.

We have access to 170,000 HCPs globally and patients in over 25 therapy areas in 30 countries.

Access to your key stakeholders, disease experts and key opinion leaders, even in rare conditions, enabling the intelligence from a wide range of respondents to be combined and triangulated.

Mobile data collection techniques, leading to an immediacy of results from both HCPs and patients. 

Richer data and insights, more closely reflecting respondents true motivations and behaviours, and underpinning actionable recommendations, robust assumptions and defendable product valuations.  

Combined experience of  over 50 years encompassing biopharmaceutical industry local and global marketing and new product commercialisation, market research and consultancy.

We have access to 170,000 HCPs globally and patients in over 25 therapy areas in 30 countries.

Mobile data collection techniques, leading to an immediacy of results from both HCPs and patients. 

Combined experience of  over 50 years encompassing biopharmaceutical industry local and global marketing and new product commercialisation, market research and consultancy.

Effective research design, analysis, and interpretation, with actionable  recommendations, robust assumptions and defendable new product valuations.

We have access to 170,000 HCPs globally and patients in over 25 therapy areas in 30 countries.

Access to your key stakeholders, disease experts and key opinion leaders, even in rare conditions, enabling the intelligence from a wide range of respondents to be combined and triangulated.

Mobile data collection techniques, leading to an immediacy of results from both HCPs and patients. 

Richer data and insights, more closely reflecting respondents true motivations and behaviours, and underpinning actionable recommendations, robust assumptions and defendable product valuations.  

iStock-1254063670.jpg

Our Process

We begin by developing a thorough understanding of your needs:

  • Shared briefing playback to ensure a common understanding

  • Investment in required level of face-to-face, Zoom, Teams, etc. meetings

  • Optional internal alignment audit 

 

We exactly translate your needs into a bespoke project design:

  • Flexible, iterative research programme design and questionnaire development

  • Collaborative planning and leadership and implementation of project

  • Close contact and frequent feedback

Polestar Insights designs research to meet your needs. We then work to ensure that exactly the right methodologies are used, and triangulate the research results with online searches, and other data sources, to enrich the insights.

We are able to employ a wide range of research methodologies, and to tailor our consultancy to meet the diverse needs of our clients.

 We deliver expert guidance 

  • In-depth analysis and interpretation

  • In-depth analysis, clear and workable strategies and tactical campaigns, actionable recommendations, robust assumptions, and defendable new product valuations

  • Continued support to implement 

  • Market and competitive landscape

  • Product forecast, assumptions and valuation

  • Target Product Profile, evidence generation plan and support for go/no go decisions

  • Patient journey understanding and validation (e.g. with disease experts (DEs) and Key Opinion Leaders (KOLs)

  • Health economics analysis

  • Treatment attributes and value drivers

  • Value proposition – value messages, ensuring stakeholder understanding

  • Develop positioning and pricing corridor

  • Healthcare services, stakeholder identification and engagement (e.g. NHS, NICE)

  • Funding flows and priorities / impact, negotiating funding model, budget impact models, reimbursement and commissioning policy

  • DE or KOLs identification, and engagement e.g. in-depth interviews and advisory boards

  • Launch excellence, launch planning

  • Product strategic options

  • Positioning, segmentation and differentiation

  • Insights including perceptions and needs, by customer group (e.g. DE/KOLs, healthcare professionals, patients, payers, providers, policy makers)

  • Develop and implement KPIs to optimise strategy and drive product awareness, usage and performance

  • Key account plan prior to launch (top accounts and access plans for them)

  • Tactical campaigns post-launch